ArticleNature medicine2025

Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial.

Stephen J Bagley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.